Pregnancy and long-term outcomes of female patients with chronic myeloid leukemia on tyrosine kinase inhibitors who experienced unplanned pregnancies

Posted on by

Publication date: October 2023

Source: Leukemia Research, Volume 133

Author(s): Urmimala Bhattacharjee, Aditya Jandial, Charanpreet Singh, KS Lekshmon, Kundan Mishra, Rajeev Sandal, Ram Nampoothiri, Shano Naseem, Vanita Suri, Arihant Jain, Deepesh P. Lad, Gaurav Prakash, Alka Khadwal, Pankaj Malhotra

Treatment strategy at the decision for allogeneic transplantation in patients with myelodysplastic syndrome in the era of azacitidine: A KSGCT prospective study

Posted on by

Publication date: October 2023

Source: Leukemia Research, Volume 133

Author(s): Shinichi Kako, Shun-ichi Kimura, Hidenori Wada, Yusuke Komiya, Hideki Nakasone, Masatoshi Sakurai, Jun Kato, Masatsugu Tanaka, Eriko Fujii, Takayoshi Tachibana, Wataru Yamamoto, Maki Hagihara, Reiko Watanabe, Akira Yokota, Hirofumi Nakano, Takehiko Mori, Chiaki Nakaseko, Heiwa Kanamori, Shinichiro Okamoto, Yoshinobu Kanda

Canadian real-world experience of asciminib treatment in heavily pre-treated chronic myeloid leukemia (CML) patients who failed multiple lines of tyrosine kinase inhibitor (TKI) therapy

Posted on by

Publication date: October 2023

Source: Leukemia Research, Volume 133

Author(s): Fatima M. Khadadah, Sonia Cerquozzi, Harold J. Olney, Christina Fraga, Jill Dudebout, Anargyros Xenocostas, Nicholas Finn, Vincent Ethier, M. Lynn Savoie, Lambert Busque, Kareem Jamani, Philip Kuruvilla, Carolyn Faught, Brian Leber, Rayan Kaedbey, Sarit E. Assouline, Dennis Kim